AstraZeneca to Acquire Pearl Therapeutics to Strengthen Respiratory Portfolio

News   Jun 12, 2013

 
AstraZeneca to Acquire Pearl Therapeutics to Strengthen Respiratory Portfolio
 
 
 

RELATED ARTICLES

First Successful Gene Therapy Trial Reported for People with Hemophilia A

News

Patients with hemophilia A who received a single infusion of an investigational gene therapy showed improved levels of the essential blood clotting protein FVIII, with 11 of 13 achieving normal or near-normal FVIII levels.

READ MORE

Oligonucleotide Drug Producers Report on Drug Impurities

News

A new addition to a series of articles that focus on important topics related to the development of oligonucleotide therapeutics presents an in-depth look at the identification, characterization, and reporting of product-related impurities.

READ MORE

Malvern Panalytical Wins Innovate UK Grant

News

Funding for 3-year-long project to lead biopharmaceutical consortium on aggregation analytics.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE